iMOST: Instant Mobile Phone Health Testing At Your Finger Tips, Replacing Inconvenient and Expensive Lab-Test
iMOST (Instant Mobile Self-Test) being developed by Essenlix is a game-changing instant mobile health self-test platform, iMOST, for allowing, in addition to professional use, a layperson to accurately perform a diagnostic/health test her/himself, anywhere (at home, point-of-care, clinics, hospitals, etc.), anytime, using a single drop of body fluid and a hand-held portable device (some are smartphone based), within minutes, at a low cost, with the results sent immediately to professionals.
iMOST is designed to be intelligently fault tolerant, delivering clinical lab-quality test results using a simple device, even when a sample, device, process, and operation are imperfect. iMOST™ is also to be versatile, using one unique sample holder platform and one instrument to test different sample types (blood, saliva, urine, swab, sputum, breath, mucus, tissue, etc.), different assays (immunoassay, colorimetric assay, cytology and pathology, nucleic acid assay, etc.) and different biomarkers (cells, proteins, nucleic acids, and small molecules).
With extensive research and development, including thousands of lab tests and extensive clinical tests, Essenlix’s iMOST platform is launching its first product "iMOST-CBC" for complete blood count (CBC) testing for research and, pending FDA approval, diagnostics (iMOST X-1 blood count is CE Mark cleared). In parallel, Essenlix has several other assays in its product pipeline.
How iMOST Works: